Propanc Biopharma, Inc. (PPCB)

Propanc Biopharma Statistics

Total Valuation

PPCB has a market cap or net worth of $46.29 million. The enterprise value is $74.98 million.

Market Cap	46.29M
Enterprise Value	74.98M

Important Dates

The next estimated earnings date is Tuesday, September 30, 2025.

Earnings Date	Sep 30, 2025
Ex-Dividend Date	n/a

Share Statistics

PPCB has 12.61 million shares outstanding.

Current Share Class	12.61M
Shares Outstanding	12.61M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+32,311.73%
Owned by Insiders (%)	65.87%
Owned by Institutions (%)	3.96%
Float	3.40M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.75
P/TBV Ratio	4.08
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.24, with a Debt / Equity ratio of 0.07.

Current Ratio	2.24
Quick Ratio	0.01
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-135.00

Financial Efficiency

Return on equity (ROE) is -767.20% and return on invested capital (ROIC) is -406.50%.

Return on Equity (ROE)	-767.20%
Return on Assets (ROA)	-298.55%
Return on Invested Capital (ROIC)	-406.50%
Return on Capital Employed (ROCE)	-296.34%
Revenue Per Employee	n/a
Profits Per Employee	-$27.70M
Employee Count	2
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-237
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +407,677.78% in the last 52 weeks. The beta is 19,200.53, so PPCB's price volatility has been higher than the market average.

Beta (5Y)	19,200.53
52-Week Price Change	+407,677.78%
50-Day Moving Average	5.86
200-Day Moving Average	4.11
Relative Strength Index (RSI)	44.20
Average Volume (20 Days)	3,503,073

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-53.89M
Pretax Income	n/a
Net Income	-55.40M
EBITDA	-53.89M
EBIT	-53.89M
Earnings Per Share (EPS)	-$51.96

Balance Sheet

The company has $50,760 in cash and $1.25 million in debt, giving a net cash position of -$1.20 million or -$0.09 per share.

Cash & Cash Equivalents	50,760
Total Debt	1.25M
Net Cash	-1.20M
Net Cash Per Share	-$0.09
Equity (Book Value)	18.09M
Book Value Per Share	1.56
Working Capital	5.39M

Cash Flow

Operating Cash Flow	-637,948
Capital Expenditures	n/a
Free Cash Flow	-637,948
FCF Per Share	-$0.05

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

PPCB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-75.09%
FCF Yield	-0.86%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on January 29, 2025. It was a reverse split with a ratio of 1:59,880.24.

Last Split Date	Jan 29, 2025
Split Type	Reverse
Split Ratio	1:59,880.24

Scores

Altman Z-Score	n/a
Piotroski F-Score	2